Most cathinone’s and other analogs such as 4-MC promotes the release of serotonin, norepinephrine, and dopamine. These analogs have been studied in vivo and in-vitro using lab rats. In the synaptosomes of the brain of rats, the results showed that 4-MC released serotonin, norepinephrine, and dopamine in the brains of rats, through transporters, SERT, NET, and DAT.

Manufacturers create research chemicals such as 4-MC so that studies can be performed in controlled laboratories to discover if the new synthetic compound can achieve the beneficial effects of the chemicals parent drug without the harsh side effects often seen with other medications that are now on the market. With 4-MC the parent drug is mephedrone which has unwanted side effects and abuse potential. However, through studies in controlled laboratories, 4-MC may have the same potential for abuse.

At this time, 4-MC can be purchased through a research chemical manufacturer for use in controlled laboratories and is not intended for human consumption.

More research should be conducted to learn more about the toxicity, abuse potential and even the amount of chemical that is left in wastewater after disposal. All of this can help the scientific community, as well as medical and mental communities, learn more about better alternatives for helping their patients. Once more is known, 4-MC may be discovered to be an alternative medication, but until that time it will remain listed with other research chemicals.